Global Injectable Drug Delivery Technology Market by Devices Growth, Trends and Forecasts (2017 - 2022)

The global injectable drug delivery market is estimated to be USD 40.5 billion for the year 2015. The market is expected to grow at a CAGR of about 18.1% during the forecasted period and reach USD 92.65 billion by the end of 2020.

Injectable drug delivery technologies allow the transport of drugs formulated in liquid form and facilitate the rapid transport of the drug into the body. It also helps in administering drugs in unconscious and comatose patients. These delivery systems are widely accepted due to their advantage of a faster onset of action with high efficacy. Also, in the recent years, this market has grown due to the increased prevalence of cancer and diabetes.

Global Injectable Drug Delivery Technology Market- Market Dynamics

The report details several driving and restraining factors for the global injectable drug delivery technology market. Some of them are listed below.


Increased prevalence of chronic diseases

Increased patient compliance

Technological advances in the form of nanotechnologies

Rising demand for biologics in the pharmaceutical industry


Possibility of injuries and infections via usage

Product recalls

Emergence of alternative drug delivery systems

Regulatory framework concerns

The market is segmented on the basis of devices, types, application, and geography. Based on the formulation, the market is segmented into two categories; conventional drug delivery and novel drug delivery. On the basis of devices, the market is segmented into conventional devices and self-injectable devices. The injectable drug delivery devices technologies market is further categorized into conventional injection devices, self-injection devices, and others (microneedles, Nano needles, and blunt needle injections). The market analysis is also provided for different geographical areas, which include North America, Europe, APAC, Middle East & Africa and Latin America.

Some of the key players in the market are:

Alkermes Inc.

Bend Research

BIND Biosciences, Inc.


Genentech Inc.

MicroCHIPS, Inc.

Pearl Therapeutics Inc.

Polymer Factory

Presage Bioscience

QLT Inc.

UCB Group

What the Report Offers

Market analysis for the injectable drug delivery technology market, with region-specific assessments and competition analysis on the global and regional scale.

Market definition along with the identification of key drivers and restraints.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their market share.

Identification and analysis of the macro and micro factors that affect the injectable drug delivery technology market on both global and regional scale.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.

Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.


1.1 Report Description

1.2 Research Methodology

1.3 Stakeholders


2.1 Key Findings

2.2 Market Overview


3.1 Market Definition

3.1.1 Introduction

3.1.2 Modes of Injectable Drug Delivery systems

3.2 Market Drivers

3.2.1 Increasing prevalence of Chronic Diseases

3.2.2 Increased Demand

3.2.3 Technological Advances

3.3 Market Limitations

3.3.1 Injuries and Infections

3.3.2 Recent Advancements

3.3.3 Regulatory Framework

3.4 Market Challenges

3.4.1 Sustainability

3.5 Market Opportunities

3.5.1 Emerging Countries

4. Global Injectable Drug Delivery Technology Market Segmentation

4.1 Types

4.2 Devices

4.3 Application

4.4 Geography

5. Global Injectable Drug Delivery Technology Device Market

5.1 Conventional Drug Delivery Devices

5.2 Self-Injectable Devices

5.2.1 Prefilled Syringes

5.2.2 Injectable Pen

5.2.3 Auto-Injectors

5.2.4 Needle-free Injectors

5.2.5 Self- flushing infusion bag


6.1 North America

6.1.1 US

6.1.2 Canada

6.2 Europe

6.2.1 UK

6.2.2 Germany

6.2.3 France

6.3 APAC

6.3.1 India

6.3.2 China

6.3.3 South Korea

6.3.4 Japan

6.4 Rest of the World

6.4.1 Brazil

6.4.2 Middle East

6.4.3 Australia

7. Competitive Landscape

7.1 Introduction

7.2 Mergers & Acquisitions

7.3 Expansions

7.4 New Product Launch

7.5 Collaborations

8. Top Company Profiles

8.1 Alkermes Inc.

8.2 Genentech Inc.

8.3 Bend Research

8.4 QLT Inc.

8.5 Endocyte

8.6 BIND Biosciences, Inc.

8.7 UCB Group (UCB)

8.8 Presage Bioscience

8.9 Polymer Factory

8.10 MicroCHIPS, Inc.

8.11 Pearl Therapeutics Inc.

8.12 Piedmont Pharmaceuticals

8.13 Zogenix, Inc.

8.14 Liquidia Technologies

8.15 Impax Laboratories Inc.

8.16 Boehringer Ingelheim

8.17 Crossject Medical Technology

8.18 Apogee Technology

8.19 Pulmatrix

8.20 Medicago

Content are not available

Choose License Type